Skip to main content

Eli Lilly is using mobile labs to study if its antibody drug can prevent Covid-19 in nursing homes

"We wanted to see if we could help people in nursing homes because the disease has been so devastating," Dr. Dan Skovronsky of Eli Lilly told CNBC.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.